Turner syndrome in adulthood

Hormone Research

Volumn 64, Issue SUPPL. 2, 2005, Pages 86-93

  Gravholt, Claus Højbjerg ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cardiovascular diseases; Glucose metabolism; Growth; Ischaemic heart disease; Liver function; Morbidity; Mortality; Puberty; Thyroid function; Turner syndrome

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; FOLLITROPIN; GESTAGEN; GROWTH HORMONE; LUTEINIZING HORMONE; OXANDROLONE; SEX HORMONE;

ANTHROPOMETRY; BODY COMPOSITION; BODY HEIGHT; BONE DENSITY; BONE MARROW BIOPSY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD GROWTH; CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; CONGENITAL HEART MALFORMATION; DRUG MEGADOSE; FEMALE INFERTILITY; FRACTURE; GONAD FUNCTION; GONADAL DYSGENESIS; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOGONADISM; LIVER FUNCTION; MENOPAUSE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OOCYTE DONATION; PRIORITY JOURNAL; PUBERTY; QUALITY OF LIFE; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL STATUS; TURNER SYNDROME; X CHROMOSOME;

ADOLESCENT; ADULT; ANDROGENS; BODY COMPOSITION; BODY HEIGHT; BONE DENSITY; CHILD; COGNITION; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; FRACTURES, BONE; HEART DEFECTS, CONGENITAL; HUMANS; HYPOTHYROIDISM; INFERTILITY, FEMALE; LIVER DISEASES; QUALITY OF LIFE; SOCIAL ADJUSTMENT; TURNER SYNDROME;

EID: 27944454458     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087763     Document Type: Conference Paper

References (60)

1. Turner HH: A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 1938;23:566-574.
2. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, Hovatta O, Hultcrantz M, Landin-Wilhelmsen K, Lin A, Lippe B, Pasquino AM, Ranke MB, Rosenfeld R, Silberbach M: Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001;86:3061-3069.
3. Nielsen J, Wohlert M: Chromosome abnormalities found among 34,910 newborn children: Results from a 13-year incidence study in Århus, Denmark. Hum Genet 1991;87:81-83.
4. Gravholt CH, Juul S, Naeraa RW, Hansen J: Prenatal and postnatal prevalence of Turner's syndrome: a registry study. Br Med J 1996;312:16-21.
5. Savendahl L, Davenport ML: Delayed diagnoses of Turner's syndrome: proposed guidelines for change. J Pediatr 2000;137:455-459.
6. Gravholt CH, Juul S, Naeraa RW, Hansen J: Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147-158.
7. Hasle H, Olsen JH, Nielsen J, Hansen J, Friedrich U, Tommerup N: Occurrence of cancer in women with Turner syndrome. Br J Cancer 1996;73:1156-1159.
8. Swerdlow AJ, Hermon C, Jacobs PA, Alberman E, Beral V, Daker M, Fordyce A, Youings S: Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet 2001;65:177-188.
9. Van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL: Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 2003;88:1119-1125.
10. Foudila T, Soderstrom AV, Hovatta O: Turner's syndrome and pregnancies after oocyte donation. Hum Reprod 1999;14:532-535.
11. Holl RW, Kunze D, Etzrodt H, Teller W, Heinze E: Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients. Eur J Pediatr 1994;153:11-16.
12. Gravholt CH, Naeraa RW, Nyholm B, Gerdes U, Christiansen E, Schmitz O, Christiansen JS: Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner syndrome: The impact of sex hormone replacement. Diabetes Care 1998;21:1062-1070.
13. Bakalov VK, Cooley MM, Quon MJ, Luo ML, Yanovski JA, Nelson LM, Sullivan G, Bondy CA: Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 2004;89:3516-3520.
14. Landin-Wilhelmsen K, Bryman I, Wilhelmsen L: Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab 2001;86:4166-4170.
15. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-333.
16. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998;280:605-613.
17. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI: A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001;345:1243-1249.
18. Gravholt CH, Naeraa RW, Fisker S, Christiansen JS: Body composition and physical fitness are major determinants of the growth hormone-IGF axis aberrations in adult Turner syndrome, with important modulations by treatment with 17-beta-estradiol. J Clin Endocrinol Metab 1997;82:2570-2577.
19. Park E: Body shape in Turner's syndrome. Hum Biol 1977;49:215-223.
20. Varrela J, Vinkka H, Alvesalo L: The phenotype of 45,X females: an anthropometric quantification. Ann Hum Biol 1984;11:53-66.
21. Gravholt CH, Naeraa RW: Reference values for body proportions and body composition in adult women with Turner's syndrome. Am J Med Genet 1997;72:403-408.
22. Stepan JJ, Musilova J, Pacovsky V: Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome. J Bone Miner Res 1989;4:193-198.
23. Landin-Wilhelmsen K, Bryman I, Windh M, Wilhelmsen L: Osteoporosis and fractures in Turner syndrome - importance of growth promoting and oestrogen therapy. Clin Endocrinol (Oxf) 1999;51:497-502.
24. Bertelloni S, Cinquanta L, Baroncelli GI, Simi P, Rossi S, Saggese G: Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone. Horm Res 2000;53:72-76.
25. Gravholt CH, Lauridsen AL, Brixen K, Mosekilde L, Heickendorff L, Christiansen JS: Marked dysproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome. A cross-sectional study. J Clin Endocrinol Metab 2002;87:2798-2808.
26. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA: Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997;16:54-63.
27. Munns CJ, Haase HR, Crowther LM, Hayes MT, Blaschke R, Rappold G, Glass IA, Batch JA: Expression of SHOX in human fetal and childhood growth plate. J Clin Endocrinol Metab 2004;89:4130-4135.
28. Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Christiansen JS: Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf) 2003;59:89-96.
29. Emans SJ, Grace E, Hoffer FA, Gundberg C, Ravnikar V, Woods ER: Estrogen deficiency in adolescents and young adults: impact on bone mineral content and effects of estrogen replacement therapy. Obstet Gynecol 1990;76:585-592.
30. Carrascosa A, Gussinye M, Terradas P, Yeste D, Audi L, Vicens-Calvet E: Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J Bone Miner Res 2000;15:2005-2010.
31. Lanes R, Gunczler P, Paoli M, Weisinger JR: Bone mineral density of prepubertal age girls with Turner's syndrome while on growth hormone therapy. Horm Res 1995;44:168-171.
32. Neely EK, Marcus R, Rosenfeld RG, Bachrach LK: Turner syndrome adolescents receiving growth hormone are not osteopenic. J Clin Endocrinol Metab 1993;76:861-866.
33. Bakalov VK, Van PL, Baron J, Reynolds JC, Bondy CA: Growth hormone therapy and bone mineral density in Turner syndrome. J Clin Endocrinol Metab 2004;89:4886-4889.
34. Khastgir G, Studd JW, Fox SW, Jones J, Alaghband-Zadeh J, Chow JW: A longitudinal study of the effect of subcutaneous estrogen replacement on bone in young women with Turner's syndrome. J Bone Miner Res 2003;18:925-932.
35. El Mansoury M, Bryman I, Berntorp K, Hanson C, Wilhelmsen L, Landin-Wilhelmsen K: Hypothyroidism is common in Turner syndrome: results of a five-year follow-up. J Clin Endocrinol Metab 2005;90:2131-2135.
36. Apter D, Lenko HL, Perheentupa J, Soderholm A, Vihko R: Subnormal pubertal increases of serum androgens in Turner's syndrome. Horm Res 1982;16:164-173.
37. Gravholt CH, Svenstrup B, Bennett P, Christiansen JS: Low androgen levels in adult Turner syndrome: Influence of female sex hormones and growth hormone status. Clin Endocrinol (Oxf) 1999;50:791-800.
38. Sylven L, Hagenfeldt K, Brondum NK, von Schoultz B: Middle-aged women with Turner's syndrome. Medical status, hormonal treatment and social life. Acta Endocrinol 1991;125:359-365.
39. Roulot D, Degott C, Chazouilleres O, Oberti F, Cales P, Carbonell N, Benferhat S, Bresson-Hadni S, Valla D: Vascular involvement of the liver in Turner's syndrome. Hepatology 2004;39:239-247.
40. Guttmann H, Weiner Z, Nikolski E, Ish-Shalom S, Itskovitz-Eldor J, Aviram M, Reisner S, Hochberg Z: Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clin Endocrinol (Oxf) 2001;54:159-164.
41. Dawson FKL, Wright AM, Bakker B, Pitlick PT, Rosenfeld RG: Cardiovascular evaluation in Turner syndrome: Utility of MR imaging. Australas Radiol 1992;36:204-209.
42. Gotzsche CO, Krag Olsen B, Nielsen J, Sorensen KE, Kristensen BO: Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 1994;71:433-436.
43. Mazzanti L, Cacciari E: Congenital heart disease in patients with Turner's syndrome. Italian Study Group for Turner Syndrome (ISGTS). J Pediatr 1998;133:688-692.
44. Sybert VP: Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998;101:E11.
45. Ho VB, Bakalov VK, Cooley M, Van PL, Hood MN, Burklow TR, Bondy CA: Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 2004;110:1694-1700.
46. Elsheikh M, Casadei B, Conway GS, Wass JA: Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol (Oxf) 2001;54:69-73.
47. Nathwani NC, Unwin R, Brook CG, Hindmarsh PC: Blood pressure and Turner syndrome. Clin Endocrinol (Oxf) 2000;52:363-370.
48. Elsheikh M, Bird R, Casadei B, Conway GS, Wass JA: The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome. J Clin Endocrinol Metab 2000;85:614-618.
49. Ross JL, Kushner H, Roeltgen DP: Developmental changes in motor function in girls with Turner syndrome. Pediatr Neurol 1996;15:317-322.
50. Bender BG, Linden MG, Robinson A: Neuropsychological impairment in 42 adolescents with sex chromosome abnormalities. Am J Med Genet 1993;48:169-173.
51. Rovet JF: The psychoeducational characteristics of children with Turner syndrome. J Learn Disabil 1993;26:333-341.
52. Ross JL, Feuillan P, Kushner H, Roeltgen D, Cutler GB Jr: Absence of growth hormone effects on cognitive function in girls with Turner syndrome. J Clin Endocrinol Metab 1997;82:1814-1817.
53. Rovet J, Holland J: Psychological aspects of the Canadian randomized controlled trial of human growth hormone and low-dose ethinyl oestradiol in children with Turner syndrome. The Canadian Growth Hormone Advisory Group. Horm Res 1993;39(suppl 2):60-64.
54. Ross JL, Roeltgen D, Feuillan P, Kushner H, Cutler GB Jr: Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome. J Clin Endocrinol Metab 1998;83:3198-3204.
55. Ross JL, Roeltgen D, Feuillan P, Kushner H, Cutler GB Jr: Use of estrogen in young girls with Turner syndrome: effects on memory. Neurology 2000;54:164-170.
56. Ross JL, Roeltgen D, Stefanatos GA, Feuillan P, Kushner H, Bondy C, Cutler GB Jr: Androgen-responsive aspects of cognition in girls with Turner syndrome. J Clin Endocrinol Metab 2003;88:292-296.
57. Elsheikh M, Dunger DB, Conway GS, Wass JA: Turner's syndrome in adulthood. Endocr Rev 2002;23:120-140.
58. Verlinde F, Massa G, Lagrou K, Froidecoeur C, Bourguignon JP, Craen M, De Schepper J, Du Caju M, Heinrichs C, François I, Maes M: Health and psychosocial status of patients with Turner syndrome after transition to adulthood: the Belgian experience. Horm Res 2004;62:161-167.
59. Delooz J, Van den Berghe H, Swillen A, Kleczkowska A, Fryns JP: Turner syndrome patients as adults: a study of their cognitive profile, psychosocial functioning and psychopathological findings. Genet Couns 1993;4:169-179.
60. Downey J, Ehrhardt AA, Gruen R, Bell JJ, Morishima A: Psychopathology and social functioning in women with Turner syndrome. J Nerv Ment Dis 1989;177:191-201.